Nevertheless, there is currently no proof estimating the effectiveness of the 14-3-3 Eta protein biomarker in JIA patients, either in identifying the disease’s activity or its role in identifying uveitis risk in JIA, and RA patients. This evidence concerns the gene YWHAH and rheumatoid arthritis.